Elix

Elix is a Tokyo-based technology company specializing in AI-driven drug discovery. The company utilizes its proprietary platform, Elix Discovery, to accelerate the drug development process through advanced machine learning and deep learning models. Elix collaborates with major pharmaceutical companies to optimize lead discovery, predict molecular properties, and design novel chemical structures. Their business model focuses on both internal asset development and strategic partnerships to reduce the time and cost associated with traditional drug R&D. The platform integrates various modules including generative models for de novo design and predictive models for ADMET properties.